Guidance for industry : changes to an approved application : biological products, human blood and blood components intended for transfusion or for further manufacture.

Bibliographic Details
Corporate Author:	Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2001]
Subjects:	Blood > Transfusion > Government policy > United States. Blood products > Evaluation > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS113200

Description
Item Description:	Title from PDF title page (viewed on May 28, 2009). "July 2001". Electronic resource.
Physical Description:	i, 30 pages : digital, PDF file.
Format:	Mode of access: Internet at the FDA CBER web site. Address as of 5/28/09: http://www.fda.gov/cber/gdlns/bldchanges.pdf ; current access is available via PURL.
Bibliography:	Includes bibliographical references (pages 25-26).